{"id":"W2519942097","doi":"","title":"Targeting cancer stem cells: Challenges and opportunities","year":2013,"lang":"en","type":"article","venue":"Journal of Bioequivalence & Bioavailability","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dasatinib; Imatinib; Stem cell; Progenitor cell; Cancer research; Cancer stem cell; Medicine; Tyrosine kinase; Myeloid leukemia; CD34; Haematopoiesis; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Population; Immunology; Cancer; Leukemia; Biology; Internal medicine; Cell biology; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001878779,0.0006154651,0.0007733362,0.001032044,0.001791064,0.003553497,0.001195158,0.002572604,0.0300759],"category_scores_gemma":[0.001719281,0.0002969746,0.000246856,0.001092191,0.002571841,0.001462523,0.00183361,0.003506578,0.00651665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01101267,"about_ca_system_score_gemma":0.0219853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1800522,"about_ca_topic_score_gemma":0.344897,"domain_scores_codex":[0.9991365,0.00006518701,0.00002485892,0.0001008925,0.0004510886,0.0002214739],"domain_scores_gemma":[0.9966739,0.0002804442,0.00007337666,0.00009246321,0.001681468,0.001198322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002041602,0.00009643884,0.001109208,0.00127757,0.00001880962,0.0004929808,0.0003628723,0.0004955356,0.01100003,0.03764976,0.4703867,0.476906],"study_design_scores_gemma":[0.00001937881,0.00005469124,0.0008416629,0.0004832169,0.00001002954,0.0002544069,0.0003011963,0.0002509213,0.001828703,0.005565764,0.9903685,0.00002160191],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009456518,0.5781622,0.00636652,0.2448661,0.009950695,0.0001564658,0.0009642957,0.0004843058,0.149593],"genre_scores_gemma":[0.05995359,0.6914658,0.008046137,0.03570081,0.003912029,0.0001886045,0.000999609,0.00018485,0.1995485],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1800522,"threshold_uncertainty_score":0.3580083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08584506014930933,"score_gpt":0.295643831768893,"score_spread":0.2097987716195837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}